Difference between revisions of "Part:BBa K3160021"
Lavenderxc (Talk | contribs) |
Lavenderxc (Talk | contribs) |
||
| (8 intermediate revisions by the same user not shown) | |||
| Line 6: | Line 6: | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
| + | |||
| + | <h2>Aim of experiment</h2> | ||
| + | |||
| + | The expression of miR-21 and miR-17 were found to be significantly associated with all tumor stage of gastric cancer. We designed miR-21-17 sensor contain complementary binding sites to miR-21 and miR-17 which inhibit miR-21 and miR-17 expression. We inserted miR-21-17 sensor into the 3’UTR of mcherry, which generated mcherry -miR-21-17 sensor. We constructed this part mcherry-miR-21-17 sensor and try to test the possibility of detecting tumor cells by using this part. | ||
| + | |||
| + | <h2>Methods</h2> | ||
| + | |||
| + | more information please link our wiki website | ||
| + | https://2019.igem.org/Team:XHD-WS-Wuhan-A/experiment/results/ | ||
| + | |||
| + | <h2>Results</h2> | ||
| + | |||
| + | The effect of mCherry-miR-21 sensor and mCherry-miR-21-17 in gastric cancer cells | ||
| + | |||
| + | The expression of miR-21 and miR-17 is associated with all stage of gastric cancer, especially metastasis stage [1, 2]. | ||
| + | We constructed this mCherry–miR-21-17 sensor [https://parts.igem.org/Part:BBa_K3160021 K3160021] ] plasmid and try to test the possibility of detecting tumor cells by using these plasmids. To detect the validity of mCherry–miR-21 sensor and mCherry–miR-21-17 sensor in cells, mCherry (as negative controls), mCherry–miR-21 sensor or mCherry–miR-21-17 sensor (0.8 ug plasmids for each well) was transfected into human gastric epithelial cells (GES-1 cells) in 24-well plate, respectively. After transfection, cells were examined under fluorescence microscopy (Fig. 1 A, B, and C). The fluorescence of mCherry was significantly decreased in GES-1 cells transfected with mCherry–miR-21 sensor compared with controls (Fig. 1 A and B). mCherry–miR-21 sensor contains binding sites of miR-21 and mCherry–miR-21-17 sensor contains binding sites of two miRNAs. Surprisingly, mCherry–miR-21 sensor transfection induced strongest inhibition of mCherry fluorescence (Fig. 1 A, B, and C). We also measured the value of mCherry fluorescence by plate reader (SpectraMax i3) (Table 1). The similar results were also observed in two gastric cancer cells (SGC-7901 and MGC-803) (Fig. 1, 2 and Table 1). The result suggested mCherry–miR-21 sensor strongly inhibited the expression of miR-21 in cells, which imply the potential possibility of this sensor in gene therapy for gastric cancer in the future. | ||
| + | |||
| + | |||
| + | https://static.igem.org/mediawiki/parts/1/1b/T--XHD-WS-Wuhan-A--miR17-21-fig_1.jpeg | ||
| + | |||
| + | https://static.igem.org/mediawiki/parts/c/ca/File-T--XHD-WS-Wuhan-A--miR17-21-fig3.jpeg | ||
| + | |||
| + | https://static.igem.org/mediawiki/parts/c/cd/T--XHD-WS-Wuhan-A--miR17-21-fig2.jpeg | ||
| + | |||
| + | https://static.igem.org/mediawiki/parts/1/17/T--XHD-WS-Wuhan-A--miR17-21-fig3.jpeg | ||
| + | |||
| + | ===References=== | ||
| + | |||
| + | 1. Song JH, Meltzer SJ. MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology. 2012 Jul;143(1):35-47. | ||
| + | |||
| + | 2. Sierzega M, Kaczor M, Kolodziejczyk P, Kulig J, Sanak M, Richter P. Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331. Br J Cancer. 2017 Jul 11;117(2):266-273. | ||
Latest revision as of 09:13, 21 October 2019
MCherry-miR-21-17 sensor
The expression of miR-21 and miR-17 were found to be significantly associated with all tumor stage of gastric cancer. We designed miR-21-17 sensor contain complementary binding sites to miR-21 and miR-17 which inhibit miR-21 and miR-17 expression. The sequences of miR-21-17 sensor were synthesized by GenScript (Shanghai, China). We inserted miR-21-17 sensor into the 3’UTR of mcherry, which generated mcherry -miR-21-17 sensor.
Usage and Biology
Aim of experiment
The expression of miR-21 and miR-17 were found to be significantly associated with all tumor stage of gastric cancer. We designed miR-21-17 sensor contain complementary binding sites to miR-21 and miR-17 which inhibit miR-21 and miR-17 expression. We inserted miR-21-17 sensor into the 3’UTR of mcherry, which generated mcherry -miR-21-17 sensor. We constructed this part mcherry-miR-21-17 sensor and try to test the possibility of detecting tumor cells by using this part.
Methods
more information please link our wiki website https://2019.igem.org/Team:XHD-WS-Wuhan-A/experiment/results/
Results
The effect of mCherry-miR-21 sensor and mCherry-miR-21-17 in gastric cancer cells
The expression of miR-21 and miR-17 is associated with all stage of gastric cancer, especially metastasis stage [1, 2]. We constructed this mCherry–miR-21-17 sensor K3160021 ] plasmid and try to test the possibility of detecting tumor cells by using these plasmids. To detect the validity of mCherry–miR-21 sensor and mCherry–miR-21-17 sensor in cells, mCherry (as negative controls), mCherry–miR-21 sensor or mCherry–miR-21-17 sensor (0.8 ug plasmids for each well) was transfected into human gastric epithelial cells (GES-1 cells) in 24-well plate, respectively. After transfection, cells were examined under fluorescence microscopy (Fig. 1 A, B, and C). The fluorescence of mCherry was significantly decreased in GES-1 cells transfected with mCherry–miR-21 sensor compared with controls (Fig. 1 A and B). mCherry–miR-21 sensor contains binding sites of miR-21 and mCherry–miR-21-17 sensor contains binding sites of two miRNAs. Surprisingly, mCherry–miR-21 sensor transfection induced strongest inhibition of mCherry fluorescence (Fig. 1 A, B, and C). We also measured the value of mCherry fluorescence by plate reader (SpectraMax i3) (Table 1). The similar results were also observed in two gastric cancer cells (SGC-7901 and MGC-803) (Fig. 1, 2 and Table 1). The result suggested mCherry–miR-21 sensor strongly inhibited the expression of miR-21 in cells, which imply the potential possibility of this sensor in gene therapy for gastric cancer in the future.
References
1. Song JH, Meltzer SJ. MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology. 2012 Jul;143(1):35-47.
2. Sierzega M, Kaczor M, Kolodziejczyk P, Kulig J, Sanak M, Richter P. Evaluation of serum microRNA biomarkers for gastric cancer based on blood and tissue pools profiling: the importance of miR-21 and miR-331. Br J Cancer. 2017 Jul 11;117(2):266-273.